NUCLEOTIDE SEQUENCE CODING TolC, CONTAINING HETEROLOGICAL AMINO-ACID SEQUENCE Russian patent published in 2008 - IPC C12N15/31 C12N1/21 C07K14/195 A61K39/108 A61K39/112 A61P31/00 

Abstract RU 2339698 C2

FIELD: medicine, microbiology.

SUBSTANCE: invention concerns nucleotide sequence coding TolC, and also to certain amino-acid sequence which is built in in permissive, located from lateral aspect of a membrane area of TolC. In the invention is described a plasmid, containing a nucleotide sequence, for an expression of the merged protein or merged peptide. The invention concerns also the transformed bacterium, in particular enterobacteria, to its use as a part of a pharmaceutical composition for stimulation of the immune response and in a diagnostic set for detection of interesting substance in an organism. The framed transport system provides high efficiency of presentation of a product of an expression in an external cellular membrane of a bacterium.

EFFECT: provision of high efficiency of presentation of product of expression in external cellular membrane of a bacterium.

13 cl, 1 dwg, 5 ex

Similar patents RU2339698C2

Title Year Author Number
MICROORGANISMS AS CARRIERS OF NUCLEOTIDE SEQUENCES ENCODING CELLULAR ANTIGENS FOR TREATMENT OF TUMORS 2003
  • Rapp Ul'F R.
  • Gebel' Verner
  • Genchev Ivajlo
  • Fensterle Joakhim
RU2319741C2
ANTIGEN AND PROTEIN TOXIC CODING NUCLEOTIDE SEQUENCE CARRIER MICROORGANISM 2007
  • Gentshev Ivajlo
  • Goehbel' Verner
  • Rapp Ul'F R.
  • Fensterle Ioakhim
RU2447145C2
MODIFIED BIOTIN-BINDING PROTEIN, FUSION PROTEINS BASED THEREON AND THEIR APPLICATION 2012
  • Molli Richard
  • Lu Intsze
  • Chzan Fan
RU2632651C2
PEPTIDE (VARIANTS) AND METHOD OF ITS PRODUCTION, PHARMACEUTICAL AGENT, ANTIBODY AND METHOD OF ITS PRODUCTION 1994
  • Khermann Katinger
  • Tomas Muster
RU2181379C2
IMMUNOGENIC COMPOSITIONS OF MULTIPLE ANTIGEN PRESENTATION, METHODS AND APPLICATIONS RELATING THERETO 2012
  • Molli Richard
  • Lu Intsze
  • Chzan Fan
RU2619176C2
METHOD FOR IMMUNOTHERAPEUTIC TREATMENT OF PROSTATE CANCER 2011
  • Kuling Bennink Kherman Yan Tejmen
RU2586774C2
PURIFIED AND ISOLATED NUCLEIC ACID MOLECULE, RECOMBINANT PLASMID, RECOMBINANT VECTOR, PURIFIED AND ISOLATED PROTEIN, PURIFIED AND ISOLATED PROTEIN D15 OR ITS PART OF EXTERNAL ENVELOPE, SYNTHETIC PEPTIDE, CHIMERIC MOLECULE, IMMUNOGENIC COMPOSITION AND ANTISERUM OR ANTIBODY 1993
  • Pele Chong
  • Vejn Tomas
  • Jan-Ping Jang
  • Shina Lusmore
  • Du Juan Charlz Sia
  • Majkl Klejn
RU2141528C1
DNA FRAGMENT AND PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT 1994
  • Shvajgkhoffer Fab'En
  • Tok Brjuno
RU2218400C2
FUSED PROTEINS OF CARCINOEMBRYONAL ANTIGEN 2005
  • La Monika Nikola
  • Fachch'Jabene Andrea
  • Aurisichch'O Luidzhi
  • Chiliberto Dzhennaro
RU2380375C2
COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSTICS OF CHLAMYDIA INFECTION 2001
  • Fling Stiven P.
  • Skejki Jasir A.V.
  • Probst Peter
  • Bkhatija Adzhej
RU2410394C2

RU 2 339 698 C2

Authors

Gebel' Verner

Genchev Ivajlo

Shpreng Simone

Dates

2008-11-27Published

2003-02-13Filed